Niederle, Bruno; Selberherr, Andreas; Bartsch, Detlef; Brandi, Maria Luisa; Doherty, Gerard M; Falconi, Massimo; Goudet, Pierre; Halfdanarson, Thorvardur R; Ito, Tetsuhide; Jensen, Robert T; Larghi, Alberto; Lee, Lingaku; Oberg, Kjell; Pavel, Marianne; Perren, Aurel; Sadowski, Samira M; Tonelli, Francesco; Triponez, Frederic; Valk, Gerlof D; O'Toole, Dermot; ... (2021). Multiple Endocrine Neoplasia Type 1 (MEN1) and the Pancreas - Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement. Neuroendocrinology, 111(7), pp. 609-630. Karger 10.1159/000511791
Text
document.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (590kB) |
The better understanding of the biological behavior of MEN1 organ manifestations and the in-crease in clinical experience warrant a revision of previously published guidelines. DP-NENs are still the second most common manifestation in MEN1 and, besides NENs of the thymus, remain a leading cause of death. DP-NENs are thus of main interest in the effort to re-evaluate recommendations for their diagnosis and treatment. Especially over the last two years, more clinical experience has documented the follow-up of treated and untreated (natural-course) DP-NENs. It was the aim of the international consortium of experts in endocrinology, genetics, radiology, surgery, gastroenterology and oncology to systematically review the literature and to present a consensus statement based on the highest levels of evidence. Reviewing the literature published over the past decade, the focus was on the diagnosis of F- and NF-DP-NENs within the MEN1 syn-drome in an effort to further standardize and improve treatment and follow-up, as well as to es-tablish a "logbook" for the diagnosis and treatment of DP-NENs. This shall help further reduce complications and improve long-term treatment results in these rare tumors. The following international consensus statement builds upon the previously published guide-lines of 2001 and 2012 and attempts to supplement the recommendations issued by various na-tional and international societies.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Perren, Aurel |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
0028-3835 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Aurel Perren |
Date Deposited: |
19 Jan 2021 14:38 |
Last Modified: |
05 Dec 2022 15:43 |
Publisher DOI: |
10.1159/000511791 |
PubMed ID: |
32971521 |
BORIS DOI: |
10.48350/150434 |
URI: |
https://boris.unibe.ch/id/eprint/150434 |